T-cell landscape mapping identifies new targets for pancreatic cancer immunotherapy
Through analysis of T-cell populations, Oxford pancreatic researchers identify novel therapeutic opportunities in pancreatic cancer patients
Entries by Oxford Centre
New clinical prediction tools for myeloma
Dr Constantinos Koshiaris has developed clinical prediction models for use in primary care with the aim of accelerating myeloma diagnoses.
Oxford at the American Association for Cancer Research Annual Meeting
Oxford researchers are out in force at next week’s AACR Annual Meeting, check out what they’ll be talking about
Early Detection Award for research into the clinical application of single cell genomics
Dr Onima Chowdhury will investigate the clinical application of single cell sequencing for early diagnosis and response prediction in myelodysplastic syndromes.
Higher testosterone levels in men linked to greater melanoma risk
New research from Dr Eleanor Watts at the Nuffield Department of Population Health has found this association for the first time
New funding for early diagnosis research using platelets
Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.
Novel imaging device enters first round of development funding programme
Anna Vella is designing CAPULET: a device to increase the accuracy in delivering particle beam radiotherapy in cancer treatment
Oxford spin out influencing patient care world wide
Oxford cancer research spin our Optellum has received FDA clearance for the world’s first AI-powered clinical decision support for early lung cancer diagnosis
Funding to improve childhood, teenage and young adult cancer detection
Dr Defne Saatci and Professor Julia Hippisley-Cox will develop risk prediction tools using the QResearch database to support the earlier detection of childhood, teenage and young adult cancer
New partnership enables access to state-of-the-art radiotherapy machine
University of Oxford, OUH and GenesisCare have partnered to provide access to a new ViewRay MRIdian machine. It is the first of its kind in the UK and will help to improve challenging cancer treatment through faster, tailored radiotherapy.
